首页|期刊导航|中华医学杂志(英文版)|Safety and efficacy of allogeneic natural killer cell immunotherapy on human immunodeficiency virus type 1 immunological non-responders:a brief report
Safety and efficacy of allogeneic natural killer cell immunotherapy on human immunodeficiency virus type 1 immunological non-responders:a brief report
Huan Xia Ping Ma Yin Wang Hua-Li Sun Li-Ying Gao Yu Cao Silvere D.Zaongo Rong-Nan Zeng Hao Wu Ming-Jie Zhang
中华医学杂志(英文版)2020,Vol.133Issue(23):2803-2807,5.
中华医学杂志(英文版)2020,Vol.133Issue(23):2803-2807,5.DOI:10.1097/CM9.0000000000001189
Safety and efficacy of allogeneic natural killer cell immunotherapy on human immunodeficiency virus type 1 immunological non-responders:a brief report
Safety and efficacy of allogeneic natural killer cell immunotherapy on human immunodeficiency virus type 1 immunological non-responders:a brief report
摘要
关键词
HIV-1/Immune reconstitution/Immunological non-responders/Immunotherapy/Natural killer cell/NK cellKey words
HIV-1/Immune reconstitution/Immunological non-responders/Immunotherapy/Natural killer cell/NK cell引用本文复制引用
Huan Xia,Ping Ma,Yin Wang,Hua-Li Sun,Li-Ying Gao,Yu Cao,Silvere D.Zaongo,Rong-Nan Zeng,Hao Wu,Ming-Jie Zhang..Safety and efficacy of allogeneic natural killer cell immunotherapy on human immunodeficiency virus type 1 immunological non-responders:a brief report[J].中华医学杂志(英文版),2020,133(23):2803-2807,5.基金项目
This study was funded by the Key Project of Tianjin Second People's Hospital (No.YS0001),the National Natural Science Foundation of China (No.82002136),and the 13th Five-year National Major Project for HIV/AIDS and Hepatitis B Control and Prevention,and the Chinese Ministry of Science and Technology (Nos.2017ZX10202102005004,2018ZX10302104-002). (No.YS0001)